SCHEMBL21761835

SCHEMBL21761835

COC(=O)C1(c2ccccc2)CCC(C)(C)CC1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.54
KMT2A Q03164 1/20 0.54
HSD11B1 P28845 2/20 0.50
HTT P42858 1/20 0.49
OPRM1 P35372 5/20 0.48
KCNA3 P22001 1/20 0.47
OPRD1 P41143 3/20 0.47
OPRK1 P41145 3/20 0.47
ADRA1A P35348 2/20 0.47
SLC22A1 O15245 1/20 0.47
SLC6A4 P31645 1/20 0.47
KCNH2 Q12809 1/20 0.47
AKR1C1 Q04828 1/20 0.46
CHRM3 P20309 1/20 0.46
HDAC4 P56524 2/20 0.45
APOBEC3A P31941 2/20 0.44
APOBEC3G Q9HC16 2/20 0.44
L3MBTL1 Q9Y468 1/20 0.44
ADRA1D P25100 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL349195 0.93 MEN1 (0.56) MEN1KMT2AHSD11B1HTTOPRM1
Iodomethane SCHEMBL3898463 0.89 MEN1 (0.53) MEN1KMT2AHSD11B1HTTOPRM1
SCHEMBL2481767 0.86 AKR1C1 (0.58) MEN1KMT2AHSD11B1HTTOPRM1
SCHEMBL1041983 0.86 AKR1C1 (0.63) MEN1KMT2AHSD11B1HTTAKR1C1
SCHEMBL1042494 0.84 HDAC4 (0.62) MEN1KMT2AHSD11B1HTTAKR1C1
SCHEMBL1038755 0.84 HDAC4 (0.62) MEN1KMT2AHSD11B1HTTAKR1C1
SCHEMBL1042365 0.84 HDAC4 (0.62) MEN1KMT2AHSD11B1HTTAKR1C1
SCHEMBL8110538 0.82 AKR1C1 (0.68) MEN1KMT2AHSD11B1AKR1C1HDAC4
SCHEMBL1626631 0.81 ALDH1A1 (0.61) MEN1KMT2AHSD11B1APOBEC3AAPOBEC3G
SCHEMBL5765569 0.81 MEN1 (0.50) MEN1KMT2AHSD11B1HTTOPRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3197879-B1 NEW BICYCLIC DERIVATIVES HAVING BETA2 ADRENERGIC AGONIST AND M3 MUSCARINIC ANTAGONIST ACTIVITIES ALMIRALL SA (ES) 2020-02-26 EP disclosed